301096 Hangzhou Bio-Sincerity Pharma-Tech
- 41.04
- +0.82+2.04%
About Hangzhou Bio-Sincerity Pharma-Tech Company
The company is a comprehensive pharmaceutical research and development listed company integrating innovative, full value chain, platform-based and inclusive attributes. It focuses on the management of the entire life cycle of drugs, and is committed to building a pharmaceutical ecological cluster, building a bridge of communication in all fields, and achieving integration and sharing high-quality development with partners. The company is a comprehensive pharmaceutical R&D enterprise with technology development as the core, integrating innovative, full value chain, platformization and inclusive attributes. It mainly provides various pharmaceutical companies and pharmaceutical R&D investment enterprises: (1) pharmaceutical technology contract research and development services (CRO business); (2) R&D technology achievement transformation services; (3) customized R&D and production services (CDMO). After years of development and accumulation, the company has been widely recognized and praised by customers in the industry. The company has become a highly competitive pharmaceutical R&D enterprise in China. Based on strong R&D strength and rich technological achievements, the company was rated as a national “high-tech enterprise”, “provincial high-tech enterprise research and development center”, and “Zhejiang High-growth Science and Technology Small and Medium Enterprise” and other honors.
Company Profile
Company Executives
- Name
- Position
- Salary
- jinfang lou
- Chairman, Directors, General Manager, Chairman of the Strategy Development Committee, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- 2.05M
- chunneng shao
- Vice Chairman, Directors, Member of the Strategy Development Committee
- 1.56M
- hongbing yan
- Directors
- 1.07M
- yifan liu
- Directors, Board Secretary, Deputy General Manager
- 712.60K
- bofan song
- Directors, Audit Committee Members
- 802.50K
- fei jia
- Directors, Deputy General Manager
- 1.05M
- cheng ren
- Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee
- 100.00K
- huilin li
- Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Members, Chairman of the Nomination Committee
- 100.00K
- yongzhou hu
- Independent Directors, Member of the Strategy Development Committee, Nomination Committee Members
- 100.00K
- yi xu
- Securities Affairs Representative
- --
- fumiao hu
- Chairman of the Supervisory Board, Auditors
- 706.30K
- hui ye
- Auditors
- 607.20K
- enguang feng
- Deputy General Manager
- 897.00K
- an chen
- Deputy General Manager
- 902.30K
- xiaoping chen
- Deputy General Manager
- 1.01M
- dongbo yan
- Chief Financial Officer
- 453.10K
- ning fan
- Employee Supervisors
- 351.90K
Analysis
Price Target
No Data
No Data